SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-17-011859
Filing Date
2017-11-13
Accepted
2017-11-13 16:32:44
Documents
82
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0917_immucellcorp.htm 10-Q 624145
2 CERTIFICATION f10q0917ex31_immucell.htm EX-31 9593
3 CERTIFICATION f10q0917ex32_immucell.htm EX-32 6002
  Complete submission text file 0001213900-17-011859.txt   5034968

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20170930.xml EX-101.INS 1015961
5 XBRL SCHEMA FILE iccc-20170930.xsd EX-101.SCH 53516
6 XBRL CALCULATION FILE iccc-20170930_cal.xml EX-101.CAL 76214
7 XBRL DEFINITION FILE iccc-20170930_def.xml EX-101.DEF 126431
8 XBRL LABEL FILE iccc-20170930_lab.xml EX-101.LAB 514504
9 XBRL PRESENTATION FILE iccc-20170930_pre.xml EX-101.PRE 321479
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 171196407
SIC: 2835 In Vitro & In Vivo Diagnostic Substances